Synthesis and antimicrobial activity of substituted (E)-1-(4-fluoro-3-methylphenyl)-3-phenylprop-2-en-1-one compounds

• Authors: S. Balaji , R. Senbagam , M. Rajarajan , R. Vijayakumar , V. Manikandan , G. Vanangamud , G. Thirunarayanan
• Languages of publication: EN

Abstracts

EN

In an effort to develop antimicrobial agents, a series of substituted (E)-1-(4-fluoro-3-methylphenyl)-3-phenylprop-2-en-1-one compounds were synthesized by crossed-aldol condensation reaction of 4-fluoro-3-methyl acetophenone with various substituted benzaldehydes in the presence of sodium hydroxide. The synthesized compounds were characterized by means of their UV, IR and NMR spectral data. The synthesized substituted (E)-1-(4-fluoro-3-methylphenyl)-3-phenylprop-2-en-1-one compounds were tested for their antibacterial and antifungal activities by the Bauer-Kirby disc diffusion method.

Keywords

EN

Antibacterial activity; Antifungal activity; Bacillus subtilis; vibrio cholera  

Discipline

• CHEMISTRY: CHEMISTRY

• Publisher: Scientific Publishing House „DARWIN”
• Journal: World Scientific News
• Year: 2016
• Volume: 52
• Pages: 14-30

References

• [1] Balaji S, Manikandan V, Senbagam R, Vijayakumar R, Rajarajan M, Vanangamudi G, Thirunarayanan G., Mintage Journal of Pharmaceutical & Medical Sciences, 52 (2016) 24-32.
• [2] Chen M, Christensen S B, Zhai L, Rasmussen MH, Theander T G, Frokjaer S, Steffensen B, Davidson J, Kharazmi A., Journal of Infective Diseases. 176 (1997) 1327-35.
• [3] Hsin-kaw H, Tai-Hua L, Pyang Wang J, Jey-Jeng W, Chun-Nan L., Pharmaceutical. Research, 15 (1998) 39-43.
• [4] Nielsen SF, Christensen SB, Cruciani G, Kharazmi A, Liljefors T., Journal of Medicinal Chemistry, 41 (1998) 4819-26.
• [5] John Anto R, Sukumaran K, Kuttan G, Rao MNA, Subbaraju V, Kuttan R., Cancer Letters 97 (1995) 33-46.
• [6] Vaya R, Belinky PA, Aviram M., Free Radical and Biological Medicine 23 (1997) 302-321.
• [7] Mukherjee S, Kumar V, Prasad AK, Raj HG, Brakhe ME, Olsen CE, Jain SC, Parmar VP., Bioorganic and Medicinal Chemistry 9 (2001) 337-46.
• [8] Indyah SA, Timmerman H, Samhoedi M,Sastrohami D, Sugiyanto H, Van Der Goot H., European Journal of Medicinal Chemistry 35 (2000) 449-456.
• [9] Kumar SK, Hager E, Catherine P, Gurulingappa H, Davidson NE, Khan SR., Journal of Medicinal Chemistry, 46 (2003) 2813-2826.
• [10] Prasad YR, Prasoona L, Rao AL, Lakshmi K, Kumar PR, Rao BG., International Journal of Chemical Sciences, 3(4) (2005) 685-689.
• [11] Ramana MV, Billa VK, Pallela VR, Muralidhar RMR, Boominathan R, Gabriel JL, Reddy EP., Bioorganic and Medicinal Chemistry, 16 (2008) 3907-3916.
• [12] Bhat AR, Athar F, Azam A., European Journal of Medicinal Chemistry, 44 (2009) 926-35.
• [13] Ozdemir Z, Kandilci HB, Gumusel BH, Calıs U, Bilgin AA., European Journal of Medicinal Chemistry, 42 (2006) 373-389.
• [14] Ozdemir A, Zitouni GT, Kaplancıklı ZA, Revial G, Guven K. European Journal of Medicinal Chemistry 42 (2007) 403-416.
• [15] Milano J, Oliveira SM, Rossato MF, Sauzem PD,Machado P, Beck P, Zanatta N, Martins MAP, Mello CF, Rubin M, Ferreira J, Bonacorso HG., European Journal of Pharmacology, 581 (2008) 86-98.
• [16] Carrion MD, Luisa C, Lopez LC,Camacho ME, Tapias V ,Escames G, Castroviejo DA, Espinosa A, Gallo MA, Entrena A., Europen Journal of Chemistry, 43 (2008) 2579-93.
• [17] Bauer AW, Kirby WMM, Sherris JC, Truck M., American Journal of Clinical Pathology, 45 (1996) 493-502.
• [18] Shendarkar GR, Savant DM, Badole KD, Waghmare GS., International Journal of Pharmaceutical Techtechnology and Research, 43 (2009) 1129-1135.
• [19] Giasuddin Ahmed M, Romman UKR, Mosaddeq Ahmed S, Kawsari Akhter, Ershad Halim MD. Bangladesh Journal of Science Ind. 42(1) (2007) 45-52.
• [20] Balaji S, Rajarajan M, Vijayakumar R, Manikandan V, Senbagam R. Vanangamudi G. Thirunarayanan G., International Letters of Chemistry, Physics and Astronomy 57 (2015) 145-155.

• Document Type: article